According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -$6.30. In 2022 the company made an earnings per share (EPS) of -$6.18 a decrease over its 2021 EPS that were of -$4.83.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.41 | 3.69% |
2022 | -$6.18 | 27.98% |
2021 | -$4.83 | 305.62% |
2020 | -$1.19 | -90.26% |
2019 | -$12.23 | -29.48% |
2018 | -$17.35 | -38.72% |
2017 | -$28.31 | -20.07% |
2016 | -$35.41 | 111.51% |
2015 | -$16.74 | -137.77% |
2014 | $44.33 | -396.77% |
2013 | -$14.94 | 10.71% |
2012 | -$13.49 | 6.4% |
2011 | -$12.68 |